Kadmon Announces Publication of Preclinical Data Demonstrating Anti-PD-L1/IL-15 Fusion Protein KD033 Achieves Robust Anti-Tumor Response
One News Page,
*NEW YORK, NY / ACCESSWIRE / February 1, 2021 / *Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced the publication of…